Table 1.
Outcome measures
| Tool | When | ||
|---|---|---|---|
| Intervention | Comparison | ||
| Primary outcome | |||
| GPAQ-MET-mins/week | Questionnaire | B, 3 F, 12 F | B, 3 F, 12 F |
| Accelerometer (activePALTM) | Reporting step count, MET-min/week, and sitting time | B, 3 F, 12 F | B, 3 F, 12 F |
| Pedometer (YAMAX Digi-walker SW-200) | Reporting step counts | B, 3 F, 12 F | - |
| Secondary outcomes | |||
| Socio-demographic data | Questionnaire | B | B |
| Height (m) | Stadiometer | B | B |
| Body weight (Kg) | Calibrated scales | B, 3 F, 12 F | B, 3 F, 12 F |
| Waist circumference (cm) | Tape measure | B, 3 F, 12 F | B, 3 F, 12 F |
| Lipid profile (mmol/l) | Blood test (venous fasted sample) | B, 3 F, 12 F | B, 3 F, 12 F |
| Blood pressure (mmHg) | Sphygmomanometer | B, 3 F, 12 F | B, 3 F, 12 F |
| aHbA1c (%) | Blood test (fasted sample) | B, 3 F, 12 F | B, 3 F, 12 F |
| Self-assessed general health | Questionnaire | B, 3 F, 12 F | B, 3 F, 12 F |
| Self-efficacy for PA | Questionnaire | B, 3 F, 12 F | B, 3 F, 12 F |
| Social support for exercise | Questionnaire | B, 3 F, 12 F | B, 3 F, 12 F |
| Cost analysis (description) | Detailed cost description | 12 F | - |
| Exit survey | Questionnaire (participants and project officers) | 12 F | - |
(B = baseline; 3 F = 3 month follow-up, 12 F = 12 month follow-up)
awhile blood collection for HbA1c at 12 month is mandatory, it is only done at baseline and 3 month if missing from the electronic health information system or recorded within more than 4 months prior to the measurement visits